173 related articles for article (PubMed ID: 8692530)
21. Plasma bone-specific alkaline phosphatase as an indicator of osteoblastic activity.
Leung KS; Fung KP; Sher AH; Li CK; Lee KM
J Bone Joint Surg Br; 1993 Mar; 75(2):288-92. PubMed ID: 8444951
[TBL] [Abstract][Full Text] [Related]
22. Does serum alkaline phosphatase level really indicate the prognosis in patients with osteosarcoma? A meta-analysis.
Gu R; Sun Y
J Cancer Res Ther; 2018 Jun; 14(Supplement):S468-S472. PubMed ID: 29970708
[TBL] [Abstract][Full Text] [Related]
23. Prognostic importance of alkaline phosphatase activity in serum from dogs with appendicular osteosarcoma: 75 cases (1990-1996).
Ehrhart N; Dernell WS; Hoffmann WE; Weigel RM; Powers BE; Withrow SJ
J Am Vet Med Assoc; 1998 Oct; 213(7):1002-6. PubMed ID: 9776998
[TBL] [Abstract][Full Text] [Related]
24. Development and validation of a pretreatment prognostic index to predict death and lung metastases in extremity osteosarcoma.
Wang B; Tu J; Yin J; Zou C; Wang J; Huang G; Xie X; Shen J
Oncotarget; 2015 Nov; 6(35):38348-59. PubMed ID: 26435480
[TBL] [Abstract][Full Text] [Related]
25. [Role of alkaline phosphatase Regan isoenzyme in prognosis of patients with osteosarcoma].
Tucci A; Saviano C; Del Prete S
Medicina (Firenze); 1990; 10(2):158-60. PubMed ID: 2273951
[TBL] [Abstract][Full Text] [Related]
26. Intraoperative radiation therapy for osteosarcoma.
Yamamuro T; Kotoura Y
Cancer Treat Res; 1993; 62():177-83. PubMed ID: 8096731
[No Abstract] [Full Text] [Related]
27. Automated and semiautomated analysis of rat alkaline phosphatase isoenzymes.
Hoffmann WE; Everds N; Pignatello M; Solter PF
Toxicol Pathol; 1994; 22(6):633-8. PubMed ID: 7732280
[TBL] [Abstract][Full Text] [Related]
28. Clinical usefulness of bone alkaline phosphatase in osteoporosis.
Kyd PA; Vooght KD; Kerkhoff F; Thomas E; Fairney A
Ann Clin Biochem; 1998 Nov; 35 ( Pt 6)():717-25. PubMed ID: 9838984
[TBL] [Abstract][Full Text] [Related]
29. High level of beta-hCG simulating pregnancy in recurrent osteosarcoma: case report and review of literature.
Leidinger B; Bielack S; Koehler G; Vieth V; Winkelmann W; Gosheger G
J Cancer Res Clin Oncol; 2004 Jun; 130(6):357-61. PubMed ID: 15042358
[TBL] [Abstract][Full Text] [Related]
30. miR-421 is a diagnostic and prognostic marker in patients with osteosarcoma.
Zhou S; Wang B; Hu J; Zhou Y; Jiang M; Wu M; Qin L; Yang X
Tumour Biol; 2016 Jul; 37(7):9001-7. PubMed ID: 26758431
[TBL] [Abstract][Full Text] [Related]
31. Glycosylation differences contribute to distinct catalytic properties among bone alkaline phosphatase isoforms.
Halling Linder C; Narisawa S; Millán JL; Magnusson P
Bone; 2009 Nov; 45(5):987-93. PubMed ID: 19631305
[TBL] [Abstract][Full Text] [Related]
32. Bone-origin alkaline phosphatase in plasma by wheat-germ lectin methods in bone disease.
Rosalki SB
Clin Chim Acta; 1994 May; 226(2):143-50. PubMed ID: 7923809
[TBL] [Abstract][Full Text] [Related]
33. Clinical utility of biochemical bone turnover markers in children and adolescents with osteosarcoma.
Ambroszkiewicz J; Gajewska J; Klepacka T; Chełchowska M; Laskowska-Klita T; Woźniak W
Adv Med Sci; 2010; 55(2):266-72. PubMed ID: 21084254
[TBL] [Abstract][Full Text] [Related]
34. Isoforms of bone alkaline phosphatase: characterization and origin in human trabecular and cortical bone.
Magnusson P; Larsson L; Magnusson M; Davie MW; Sharp CA
J Bone Miner Res; 1999 Nov; 14(11):1926-33. PubMed ID: 10571693
[TBL] [Abstract][Full Text] [Related]
35. [Biochemical bone turnover markers in patients with conventional and nonconventional osteosarcoma].
Ambroszkiewicz J; Gajewska J; Klepacka T; Bilska K; Woźniak W; Laskowska-Klita T
Pol Merkur Lekarski; 2006 Oct; 21(124):330-4. PubMed ID: 17205770
[TBL] [Abstract][Full Text] [Related]
36. Measurement of bone alkaline phosphatase and relative study with osteosarcoma.
Yang Z; Huo Y; Sun G; Li J; Li X
Front Med China; 2007 Feb; 1(1):54-7. PubMed ID: 24557618
[TBL] [Abstract][Full Text] [Related]
37. The age dependent levels of serum ALP isoenzymes and the diagnostic significance of corticosteroid-induced ALP during long-term glucocorticoid treatment.
Syakalima M; Takiguchi M; Yasuda J; Hashimoto A
J Vet Med Sci; 1997 Oct; 59(10):905-9. PubMed ID: 9362039
[TBL] [Abstract][Full Text] [Related]
38. Effect of chronic renal failure on bone turnover and bone alkaline phosphatase isoforms.
Magnusson P; Sharp CA; Magnusson M; Risteli J; Davie MW; Larsson L
Kidney Int; 2001 Jul; 60(1):257-65. PubMed ID: 11422759
[TBL] [Abstract][Full Text] [Related]
39. Plasma proteome predicts chemotherapy response in osteosarcoma patients.
Li Y; Dang TA; Shen J; Hicks J; Chintagumpala M; Lau CC; Man TK
Oncol Rep; 2011 Feb; 25(2):303-14. PubMed ID: 21165584
[TBL] [Abstract][Full Text] [Related]
40. Monoclonal antibodies against tissue-nonspecific alkaline phosphatase. Report of the ISOBM TD9 workshop.
Magnusson P; Arlestig L; Paus E; Di Mauro S; Testa MP; Stigbrand T; Farley JR; Nustad K; Millán JL
Tumour Biol; 2002; 23(4):228-48. PubMed ID: 12499779
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]